Ibex Medical Analytics

AI-powered Cancer Diagnostics for Pathologists

Health Tech & Life Sciences
Active
Series C Tel Aviv-Yafo Founded 2016
Total raised
$116.6M
Last: Series C 2023-09
Stage
Series C
Founded
2016
Headcount
104
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Ibex Medical Analytics uses artificial intelligence technology to develop clinical-grade solutions designed to detect cancer as accurately as a human pathologist. The companys Galen platform uses algorithms to analyze images, detect and grade cancer in biopsies, and point to other findings with high clinical importance, helping pathologists to reduce diagnostic error rates and enable a more efficient workflow. Deployed worldwide, Ibexs Galen Prostate and Galen Breast are AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases. In addition, the company is developing computational prognostic and predictive tests that will enable enhanced patient population stratification and quicker personalized treatment selection.

Funding history · 5 rounds · $116.6M total

2023-09
Series C $55.0M
2022-11
Undisclosed $10.0M
2021-03
Series B $38.0M
2019-03
Series A $11.0M
2018-02
Seed $2.6M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningComputer Vision
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratoriesConsumersDemographics & FamilyWomen
Business model
B2B

Highlights

1 PatentsVerified

Tags

artificial-intelligencedoctorsdigital-healthcarediagnosticsmachine-learningmedical-image-analysisoncologylaboratoriesprecision-medicinebiopsycomputer-visiondecision-supporthospitalsbig-dataclinicsemrwomen-healthwomenpersonalization